Metabolic response prediction using 68Ga-FAPI PET/CT in Non-Hodgkin lymphoma treated with chemotherapy: a pilot study
Abstract Background The aim of this study was to investigate the prediction value of metabolic response using gallium 68 (68Ga) labeled fibroblast-activation protein inhibitor (68Ga-FAPI) positron emission tomography-computed tomography (PET/CT) in Non-Hodgkin lymphoma (NHL) patients receiving (cycl...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2025-06-01
|
| سلاسل: | Cancer Imaging |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s40644-025-00890-0 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|